Innovate to Save Lives Act

The Innovate to Save Lives Act creates a new 10% federal tax credit for small businesses that spend money on research to combat specific drug threats. It directly affects small businesses conducting qualifying research focused on mitigating the effects of fentanyl, methamphetamine, or emerging drugs designated as threats. The credit applies to eligible research expenses related to discovering ways to treat drug use, prevent it, or reduce its harm, excluding most clinical research unless it follows NIH guidelines. The bill defines "fentanyl-related substances" by specific chemical structures and requires a government report five years after enactment to track the credit's use.